BET Inhibitors Target the SCLC-N Subtype of Small-Cell Lung Cancer by Blocking NEUROD1 Transactivation
Haobin Chen(Washington University in St. Louis), David S. Schrump(National Institutes of Health), Lisa Gesumaria(National Cancer Institute), Dinah S. Singer(United States Department of Health and Human Services), Young-Kwon Park(National Institute of Diabetes and Digestive and Kidney Diseases), Trudy G. Oliver(Duke University), Kai Ge(West Anhui University)
Cited by 29
Related Papers
Distinct roles of GCN5/PCAF‐mediated H3K9ac and CBP/p300‐mediated H3K18/27ac in nuclear receptor transactivation
|The EMBO Journal|2010|904
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Adenovirus-Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer
|JNCI Journal of the National Cancer Institute|1999|497
Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2025
|Nucleic Acids Research|2024|362